{"id":"https://openalex.org/W3085180897","doi":"https://doi.org/10.22159/ijap.2020v12i5.38651","title":"FORMULATION AND EVALUATION OF IVABRADINE HYDROCHLORIDE LOADED TRANSFERSOMAL GEL FOR TRANSDERMAL DELIVERY","display_name":"FORMULATION AND EVALUATION OF IVABRADINE HYDROCHLORIDE LOADED TRANSFERSOMAL GEL FOR TRANSDERMAL DELIVERY","publication_year":2020,"publication_date":"2020-08-11","ids":{"openalex":"https://openalex.org/W3085180897","doi":"https://doi.org/10.22159/ijap.2020v12i5.38651","mag":"3085180897"},"language":"en","primary_location":{"id":"doi:10.22159/ijap.2020v12i5.38651","doi":"https://doi.org/10.22159/ijap.2020v12i5.38651","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ijap.2020v12i5.38651","pdf_url":null,"source":{"id":"https://openalex.org/S2764477652","display_name":"International Journal of Applied Pharmaceutics","issn_l":"0975-7058","issn":["0975-7058"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Applied Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.22159/ijap.2020v12i5.38651","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018338859","display_name":"Gita Chaurasia","orcid":"https://orcid.org/0009-0002-3375-8128","observed_orcids":["https://orcid.org/0009-0002-3375-8128"]},"institutions":[{"id":"https://openalex.org/I2801027606","display_name":"RKDF University","ror":"https://ror.org/01rfr0p20","country_code":"IN","type":"education","lineage":["https://openalex.org/I2801027606"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"GITA CHAURASIA","raw_affiliation_strings":["Department of Pharmaceutics, RKDF University, Bhopal, M. P. India 462033"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, RKDF University, Bhopal, M. P. India 462033","institution_ids":["https://openalex.org/I2801027606"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005907834","display_name":"Narendra Kumar Lariya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801027606","display_name":"RKDF University","ror":"https://ror.org/01rfr0p20","country_code":"IN","type":"education","lineage":["https://openalex.org/I2801027606"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"NARENDRA LARIYA","raw_affiliation_strings":["Department of Pharmaceutics, RKDF University, Bhopal, M. P. India 462033"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, RKDF University, Bhopal, M. P. India 462033","institution_ids":["https://openalex.org/I2801027606"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2801027606"],"apc_list":null,"apc_paid":null,"fwci":0.0978,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.31626105,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":null,"issue":null,"first_page":"295","last_page":"301"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ivabradine-hydrochloride","display_name":"ivabradine hydrochloride","score":0.996999979019165},{"id":"https://openalex.org/keywords/transfersomes","display_name":"transfersomes","score":0.7839999794960022},{"id":"https://openalex.org/keywords/transdermal-drug-delivery","display_name":"transdermal drug delivery","score":0.925000011920929},{"id":"https://openalex.org/keywords/topical-gel","display_name":"topical gel","score":0.6809999942779541},{"id":"https://openalex.org/keywords/stable-angina","display_name":"stable angina","score":0.8579999804496765},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.9309999942779541},{"id":"https://openalex.org/keywords/liposomes","display_name":"liposomes","score":0.5099999904632568},{"id":"https://openalex.org/keywords/surfactants","display_name":"surfactants","score":0.5249999761581421},{"id":"https://openalex.org/keywords/sodium-deoxycholate","display_name":"sodium deoxycholate","score":0.7960000038146973},{"id":"https://openalex.org/keywords/tween-80","display_name":"Tween 80","score":0.7170000076293945},{"id":"https://openalex.org/keywords/span-80","display_name":"Span 80","score":0.9779999852180481},{"id":"https://openalex.org/keywords/carbopol-940","display_name":"Carbopol 940","score":0.7900000214576721},{"id":"https://openalex.org/keywords/ex-vivo-skin-permeation","display_name":"ex vivo skin permeation","score":0.8199999928474426},{"id":"https://openalex.org/keywords/deformability-index","display_name":"deformability index","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7424381375312805},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5861936807632446},{"id":"https://openalex.org/C50670333","wikidata":"https://www.wikidata.org/wiki/Q907651","display_name":"Permeation","level":3,"score":0.5649839639663696},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.5341927409172058},{"id":"https://openalex.org/C169222746","wikidata":"https://www.wikidata.org/wiki/Q4116558","display_name":"Factorial experiment","level":2,"score":0.5005841255187988},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.46563899517059326},{"id":"https://openalex.org/C2779564620","wikidata":"https://www.wikidata.org/wiki/Q241595","display_name":"Lecithin","level":2,"score":0.4366161823272705},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.237254798412323},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.150289386510849},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.08059030771255493},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22159/ijap.2020v12i5.38651","doi":"https://doi.org/10.22159/ijap.2020v12i5.38651","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ijap.2020v12i5.38651","pdf_url":null,"source":{"id":"https://openalex.org/S2764477652","display_name":"International Journal of Applied Pharmaceutics","issn_l":"0975-7058","issn":["0975-7058"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Applied Pharmaceutics","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.22159/ijap.2020v12i5.38651","doi":"https://doi.org/10.22159/ijap.2020v12i5.38651","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ijap.2020v12i5.38651","pdf_url":null,"source":{"id":"https://openalex.org/S2764477652","display_name":"International Journal of Applied Pharmaceutics","issn_l":"0975-7058","issn":["0975-7058"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Applied Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3047721054","https://openalex.org/W3101282339","https://openalex.org/W2288050834","https://openalex.org/W4417421768","https://openalex.org/W4281569741","https://openalex.org/W6912571796","https://openalex.org/W2991467344","https://openalex.org/W2617043629","https://openalex.org/W2132614279","https://openalex.org/W7142367433"],"abstract_inverted_index":{"Objective:":[0],"Aim":[1],"of":[2,21,36,52,148,234,270,342,353,365],"this":[3],"study":[4,93,230,262],"was":[5,97,108,135,151,173,204,215,257,286,306,329],"to":[6,45,247,250,288,369],"develop":[7],"the":[8,226,240,336,354],"topical":[9],"delivery":[10,364],"containing":[11],"ivabradine":[12],"hydrochloride":[13],"(IVH)":[14],"loaded":[15,367],"transpersonal":[16],"gel":[17,134,180,256,328],"for":[18,76,137,179,254,326,360],"symptomatic":[19],"treatment":[20],"chronic":[22],"stable":[23],"angina":[24],"pectoris":[25],"in":[26,59,89,175,202,209,239,362],"coronary":[27],"artery":[28],"disease.":[29],"Methods:":[30],"Different":[31],"hydrophilic-lipophilic":[32],"balance":[33],"(HLB)":[34],"values":[35],"surfactants-tween-80,":[37],"span-80":[38],"and":[39,55,87,94,103,145,169,177,192,221,242,295,312,339,357,372],"sodium":[40],"deoxycholate":[41],"(SDC)":[42],"were":[43,74,245],"investigated":[44],"prepare":[46],"transfersomes":[47],"(TFs)respectively,":[48],"with":[49,117,153],"different":[50],"concentration":[51],"soya":[53],"phosphatidylcholine":[54],"10%":[56],"v/v":[57],"ethanol":[58],"phosphate":[60],"buffer":[61],"solution":[62,122,191],"(pH":[63],"6.8)":[64],"by":[65,110,126,156,274],"conventional":[66],"rotary":[67],"evaporation":[68],"sonication":[69],"method.":[70],"The":[71,132,236,281],"prepared":[72,109,155],"formulations":[73,343],"evaluated":[75,136],"percentage":[77],"entrapment":[78],"efficiency":[79],"(%EE),":[80],"deformability":[81],"index":[82],"(DI),":[83],"turbidity,":[84],"vesicle":[85],"shape":[86,233],"size,":[88],"vitro":[90,183],"drug":[91,140,184,190,200,237,271,282,363],"release":[92,185],"stability.":[95],"SEM":[96,229],"done":[98],"on":[99],"selected":[100,178],"formulation":[101,105,194],"F8":[102],"liposome":[104],"(LF).":[106],"Gel":[107],"using":[111],"carbopol-940":[112],"as":[113,123],"a":[114],"gelling":[115],"agent":[116],"propylene":[118],"glycol,":[119],"polyethylene":[120],"glycol":[121],"permeation":[124,143,261,269],"enhancer":[125],"32":[127],"factorial":[128],"design":[129],"optimization":[130],"methods.":[131],"developed":[133,327],"pH,":[138,337],"viscosity,":[139],"content,":[141],"ex-vivo":[142],"studies":[144,147,320],"stability":[146,371],"TFs-gel.":[149],"This":[150],"compared":[152],"LF-gel":[154,294,311],"same":[157],"procedure.":[158],"Results:":[159],"Maximum":[160],"%":[161,198],"EE":[162],"(78.4\u00b10.94),":[163],"suitable":[164,323],"vesicular":[165],"size":[166],"(128.6":[167],"nm)":[168],"maximum":[170,206],"DI":[171],"(34.9\u00b11.9)":[172],"found":[174,205,246,287],"TFs-TW-80":[176,203,368],"development.":[181],"In":[182],"data":[186],"from":[187,263,284,304],"TFs-TW-80,":[188],"plain":[189,227,301],"liposomal":[193],"(LF)":[195],"revealed":[196],"that":[197,268,322],"cumulative":[199],"released":[201,283],"(89.5\u00b10.12":[207],"%)":[208],"20":[210],"min":[211],"than":[212,219,225,278,293,300,310,316],"others.":[213],"It":[214],"2.1":[216],"times":[217,223,291,298,308,314],"higher":[218,224,292,299],"LF":[220,243],"3.3":[222],"drug.":[228,302,318],"showed":[231,267],"spherical":[232],"vesicles.":[235],"contents":[238],"TFs":[241],"gels":[244],"be":[248,289],"92":[249],"95%w/w.":[251],"Partition":[252],"coefficient":[253],"TFs-loaded":[255],"1.04\u00b10.03.":[258],"Ex":[259],"vivo":[260],"hairless":[264],"rat":[265],"skin":[266],"is":[272],"described":[273],"firstly":[275],"first-order":[276],"kinetics":[277],"zero-order":[279],"kinetics.":[280],"TFs-gel":[285,305],"1.7":[290],"about":[296],"1.9":[297],"Flux":[303],"2.04":[307],"greater":[309],"3.28":[313],"more":[315],"plan":[317],"Stability":[319],"indicated":[321],"storage":[324],"condition":[325],"temperature":[330],"25":[331],"\u00b0C":[332],"or":[333],"less,":[334],"where":[335],"potency":[338],"therapeutic":[340],"efficacy":[341],"remain":[344],"constant.":[345],"Conclusion:":[346],"Thus,":[347],"transdermal":[348],"route":[349],"has":[350],"become":[351],"one":[352],"most":[355],"successful":[356],"innovative":[358],"focus":[359],"research":[361],"IVH":[366],"increase":[370],"bioavailability.":[373]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-09-21T00:00:00"}